RAC 0.97% $1.54 race oncology ltd

RAC - Charts & Price Action, page-18424

  1. 19,095 Posts.
    lightbulb Created with Sketch. 5902
    Sounds like a terrible experience

    Yes nobody would get a central line if they had a choice - not only is it very painful it comes with serious risks. Sometimes central lines are unavoidable, but if you want to maximise the commercial potential of your drug you would do everything you can to enable peripheral IV infusion instead.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.